D-0439-2024 Class II Ongoing

Recalled by Teva Pharmaceuticals USA, Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
April 17, 2024
Initiation Date
March 28, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,304 3x10-cartons

Product Description

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15

Reason for Recall

Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 100044259, Exp 06/30/2025.